UnitedHealth targets 3.6% net margin as strategy shifts from growth

UnitedHealth Group Inc. expects net margin to improve to about 3.6% in 2026 from 2.7% a year earlier, prioritizing profitability over the rapid enrollment growth that defined its prior strategy.

"The shift reflects a recognition that the Medicare Advantage market no longer rewards scale without underwriting discipline," said Ana Gupte, senior healthcare analyst at Leerink Partners. "UnitedHealth is repricing plans and exiting unprofitable markets to protect returns."

In the first quarter, adjusted earnings topped consensus expectations while the medical care ratio improved 90 basis points year over year to 83.9%, showing better control over medical costs. The company also raised its full-year adjusted EPS outlook. The MCR of 83.9% means UnitedHealth paid about 84 cents of every premium dollar on medical claims, down from nearly 85 cents in the prior-year period.

The strategic reset carries risk. Slowing enrollment growth could disappoint investors who bought the stock for its expansion story, while competitors Cigna Group and Elevance Health Inc. pursue similar margin-focused strategies. The question is whether UnitedHealth can sustain earnings momentum without the membership gains that once drove its premium revenue.

Optum's Role in the Turnaround

UnitedHealth's turnaround is not solely about cost cuts. Optum, its health services division, remains the primary growth engine, expanding in value-based care, specialty pharmacy and technology-enabled services. These businesses carry higher margins than traditional insurance and provide a buffer against medical cost inflation in the Medicare Advantage book.

The company is also restructuring its pharmacy benefit management business, introducing a transparent fee-based pricing model that replaces the traditional rebate-driven system. The move aims to strengthen client relationships and reduce regulatory risk as Washington scrutinizes PBM practices.

Peers Face Similar Pressures

UnitedHealth is not alone in adapting to a tougher environment. Cigna Group is leaning on its Evernorth health services unit, which includes specialty pharmacy and AI-powered care solutions. The recent launch of Pharmacy Forward shows Cigna's focus on simplifying specialty drug management while supporting earnings growth.

Elevance Health, meanwhile, continues to invest in its Carelon platform, expanding value-based care and integrated health services. The company has emphasized disciplined pricing and medical cost management as industry-wide headwinds persist.

For all three insurers, the challenge is the same: maintain margins without sacrificing the membership base that generates premium revenue. UnitedHealth's early results suggest the strategy is gaining traction, but the full test will come as 2027 Medicare Advantage bids are submitted later this year.

This article is for informational purposes only and does not constitute investment advice.